Welcome to ESGCT

The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.

The ESGCT and SFTCG Collaborative Congress 2012 will take place in the beautiful city of Versailles from October 26th to 29th 2012.
The programme is currently being drafted and registration and abstract submission will open in a few months.
To keep up to date with announcements and news, including being alerted when registration for the Versailles congress is open, enter your email address in the ‘Keep Informed’ box at the bottom of this page.
We look forward to seeing you in Versailles!

ESGCT AND SFTCG COLLABORATIVE CONGRESS 2012

26 - 29 OctobER 2012, VERSAILLES, FRANCE

 

 

ESGCT AND SFTCG COLLABORATIVE CONGRESS 2012

   News, Meetings & Events

Genome Engineering: Research & Applications More information Published: 11 October 2011 Author: ESGCT Further Reading Conference...
Clinical progress in gene therapy: Sustained partial correction of the bleeding disorder in patients suffering from severe hemophilia B More...
The European Medicines Agency has recently released a draft reflection paper on risk based quality management in clinical trials. More...
Gene therapy fulfilling its promise More information Published: 11 May 2009 Author: Thierry VandenDriessche, PhD Dear ESGCT members and...

 

thumb-bookcover


Human Gene Therapy Journal

Official Journal of the British Society for Gene Therapy.

Find out more information about the Human Gene Therapy Journal

 

 


A Letter from the President

European Society of Gene and Cell Therapy (ESGCT) is one of the leading organizations in the field and is committed to offer continuous support to basic and translational research and clinical applications of gene and cell therapy for inherited and acquired diseases. Many of the recent advances have been made in Europe and ESGCT has played an active role in increasing awareness of gene and cell therapy through...

Seppo Ylä-Herttuala, MD, PhD, FESC
President ESGCT

Read more of the President's letter


  •  
    Keep Informed
  •  
    Enter your email address to be kept up to date with news from ESGCT and the Annual Congress
  •  
  •  

Introduction to Gene Therapy

Please click on the following link to watch a 20 minute video which will tell you more about Gene Therapy.

www.clinigene.eu/video-intro-gene-therapy.html

Sponsors

ESGCT is very grateful for support
from our partners

Platinum Sponsors

By A Website Design

Gold Sponsors

By A Website Design

Silver Sponsors

By A Website Design